HomeCompareEXHI vs MRK

EXHI vs MRK: Dividend Comparison 2026

EXHI yields 550.96% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXHI wins by $131109.99M in total portfolio value
10 years
EXHI
EXHI
● Live price
550.96%
Share price
$0.36
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$131110.05M
Annual income
$96,614,871,566.45
Full EXHI calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EXHI vs MRK

📍 EXHI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXHIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXHI + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXHI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXHI
Annual income on $10K today (after 15% tax)
$46,831.96/yr
After 10yr DRIP, annual income (after tax)
$82,122,640,831.48/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EXHI beats the other by $82,122,632,503.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXHI + MRK for your $10,000?

EXHI: 50%MRK: 50%
100% MRK50/50100% EXHI
Portfolio after 10yr
$65555.05M
Annual income
$48,307,440,682.30/yr
Blended yield
73.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EXHI
No analyst data
Altman Z
32.5
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXHI buys
0
MRK buys
0
No recent congressional trades found for EXHI or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXHIMRK
Forward yield550.96%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$131110.05M$56.8K
Annual income after 10y$96,614,871,566.45$9,798.13
Total dividends collected$128177.62M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EXHI vs MRK ($10,000, DRIP)

YearEXHI PortfolioEXHI Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$65,796$55,096.42$11,206$366.19+$54.6KEXHI
2$409,201$338,798.79$12,650$502.35+$396.6KEXHI
3$2,407,057$1,969,211.92$14,407$694.19+$2.39MEXHI
4$13,401,311$10,825,760.17$16,585$967.82+$13.38MEXHI
5$70,668,858$56,329,454.95$19,342$1,363.89+$70.65MEXHI
6$353,224,047$277,608,368.85$22,913$1,947.19+$353.20MEXHI
7$1,674,743,652$1,296,793,921.74$27,662$2,823.89+$1674.72MEXHI
8$7,538,235,635$5,746,259,927.48$34,159$4,173.35+$7538.20MEXHI
9$32,238,483,875$24,172,571,745.62$43,337$6,308.80+$32238.44MEXHI
10$131,110,049,313$96,614,871,566.45$56,776$9,798.13+$131109.99MEXHI

EXHI vs MRK: Complete Analysis 2026

EXHIStock

Exlites Holdings International, Inc. engages in the consumer health care market and durable medical supply businesses. It offers consumer products, such as battery operated heated steering wheel products, electronic hot and cold packs, spring loaded shoe insoles, and other consumer products. The company is also involved in contract manufacturing of medical supplies and devices to hospitals, nursing homes, and assisted living facilities, as well as for individuals. Exlites Holdings International, Inc. distributes its products to consumer and medical distributors through catalogs and retailers, as well as directly to consumer venues. The company was founded in 1979 and is headquartered in Salt Lake City, Utah.

Full EXHI Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EXHI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXHI vs SCHDEXHI vs JEPIEXHI vs OEXHI vs KOEXHI vs MAINEXHI vs JNJEXHI vs ABBVEXHI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.